Jon Cohen

Directeur Général chez TALKSPACE, INC. Fortune : 15 M $ au 31/05/2026

Profil

Jon Roger Cohen currently works at Talkspace, Inc., as Chief Executive Officer & Director from 2022, AmeriPath, Inc., as President & Director, Celera Corp., as Director from 2011, and New York Foundling, Inc., as Trustee from 2022.
Dr. Cohen also formerly worked at Bio-Reference Laboratories, Inc., as Executive Chairman & Chief Executive Officer, OPKO Health, Inc., as Director & Senior Vice President from 2019 to 2022, Quest Diagnostics, Inc., as Senior VP and Group Executive – Diagnostics from 2009 to 2018, Quest Diagnostics, Inc., as MD-Health Industries Advisory Services from 2007 to 2008, Inuvo, Inc., as Senior Vice President, PricewaterhouseCoopers LLP, as MD-Health Industries Advisory Services in 2008, Northwell Health, Inc., as Chief Medical Officer in 2006, and Albert Einstein College of Medicine, Inc., as Professor.
Dr. Cohen received his undergraduate degree from the University of Miami and doctorate degree from The University of Miami Leonard M.
Miller School of Medicine.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
TALKSPACE, INC. 1,7%	12/06/2026	2 851 880 ( 1,7% )	15 M $	31/05/2026

Postes actifs de Jon Cohen

Sociétés	Poste	Début
TALKSPACE, INC.	Directeur Général	09/11/2022
Celera Corp.	Directeur/Membre du Conseil	05/05/2011
AmeriPath, Inc.	President	-
New York Foundling, Inc.	Directeur/Membre du Conseil	01/01/2022

Anciens postes connus de Jon Cohen

Sociétés	Poste	Fin
BIO-REFERENCE LABORATORIES INC	Directeur Général	16/08/2022
OPKO HEALTH, INC.	Directeur/Membre du Conseil	16/08/2022
QUEST DIAGNOSTICS INCORPORATED	Directeur Technique/Scientifique/R&D	01/01/2018
QUEST DIAGNOSTICS INCORPORATED	Corporate Officer/Principal	01/01/2008
PricewaterhouseCoopers LLP	Corporate Officer/Principal	01/01/2008